Guillermo Montalban‐Bravo

Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia

Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi et al. · Journal of Clinical Oncology · 2021 · 334 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch et al. · The Lancet Haematology · 2020 · 331 citations · Full text

Medicine, Hematology, Oncology +16

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Nicholas J. Short, Nitin Jain et al. · The Lancet Haematology · 2022 · 239 citations

Medicine, Hematology, Oncology +12

Myelodysplastic syndromes: 2018 update on diagnosis, risk‐stratification and management

Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero · American Journal of Hematology · 2017 · 216 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic and therapeutic impacts of mutant <i>TP53</i> variant allelic frequency in newly diagnosed acute myeloid leukemia

Nicholas J. Short, Guillermo Montalban‐Bravo, Hyunsoo Hwang et al. · Blood Advances · 2020 · 181 citations · Full text

Medicine, Oncology, Pharmacology +13